 | Up a level |
2021
Schuster, Stephen J., Tam, Constantine S., Borchmann, Peter, Worel, Nina, McGuirk, Joseph P., Holte, Harald, Waller, Edmund K., Jaglowski, Samantha, Bishop, Michael R., Damon, Lloyd E., Foley, Stephen Ronan, Westin, Jason R., Fleury, Isabelle, Ho, P. Joy, Mielke, Stephan 
ORCID: 0000-0002-8325-9215, Teshima, Takanori, Janakiram, Murali, Hsu, Jing-Mei, Izutsu, Koji, Kersten, Marie Jose, Ghosh, Monalisa, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Martinez-Prieto, Marcela, Han, Xia, Tiwari, Ranjan, Salles, Gilles and Maziarz, Richard T.
(2021).
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol., 22 (10).
S. 1403 - 1416.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488